Zenas Biopharma Stock Company Profile

Description

The investment seeks daily investment results, before fees and expenses, that correspond to three times the inverse (-3x) of the daily performance of the NASDAQ Biotechnology Index®. The fund invests in derivatives that the advisor believes, should have similar daily return characteristics as three times the inverse of the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.